Market Research Reports, Inc.

Epilepsy Drugs Market in Europe to Grow at a CAGR of 3.22% During 2014-2019; Finds New Report

Market Research Reports, Inc. has announced the addition of “Epilepsy Drugs Market in Europe - Market Analysis 2015-2019” research report to their website


Lewes, DE -- (SBWIRE) -- 10/06/2015 -- Report forecast the epilepsy drugs market in Europe to grow at a CAGR of 3.22% over the period 2014-2019.

Epilepsy refers to a spectrum of brain disorders manifested by benign to severe, disabling, and life-threatening symptoms. It is caused by factors ranging from brain malformations and tumors to meningitis, high-risk pregnancies, and trauma during birth. When the underlying cause of the disease is unidentified, as is witnessed in the majority of cases, it is known as idiopathic epilepsy. An imbalance between the inhibitory and excitatory signals of the brain, leading to a sudden onset of excitation, results in seizures.

The report includes the present scenario and the growth prospects of the epilepsy drugs market in Europe for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of epilepsy.

Epilepsy Drugs Market in Europe 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market size and forecast as well as market segmentation and pipeline landscape. The report includes a discussion of the key vendors operating in this market.

According to the report, growing patient population will lead to an increase in the consumption of anti-epileptic drugs. The market has significant levels of unmet medical needs. Currently, there are no safe and efficient disease-modifying drugs present in the market. Available drugs have many side effects, which decreases patient compliance. Any drug that can completely cure the disease will drive the market.

Key players in the Epilepsy Drugs Market in Europe: Eisai, UCB Pharma, Pfizer and GlaxoSmithKline

Other Prominent Vendors in the market are: AbbVie, Roche, Lundbeck, Janssen Pharmaceuticals, Meda, Novartis, Shire, Sunovion Pharmaceuticals, Supernus Pharmaceuticals, Upsher-Smith, and Valeant Pharmaceuticals.

Market driver
- Unmet medical needs
- For a full, detailed list, view our report

Market challenge
- Patent expiry
- For a full, detailed list, view our report

Market trend
- Reformulation of marketed drugs
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 64 pages "Epilepsy Drugs Market in Europe - Market Analysis 2015-2019" report covers Executive Summary, Scope of the Report, Market Research Methodology, Introduction, Epilepsy: An overview, Pipeline portfolio, Market landscape, Market segmentation by generation of drugs, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For further information on this report, please visit-

Related Reports:

Global Hemophilia A Market 2015-2019 - visit at:

Global Hemophilia B Market 2015-2019 - Industry Analysis - visit at:

Global HER2-Negative Breast Cancer Market 2015-2019 - visit at:

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Yearly/Quarterly Report Subscription: